Fig. 3: Precision analyses focused on treatment response were mostly part of primary trial papers, tended to be post hoc, and were biased toward positive findings. | Communications Medicine

Fig. 3: Precision analyses focused on treatment response were mostly part of primary trial papers, tended to be post hoc, and were biased toward positive findings.

From: Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review

Fig. 3: Precision analyses focused on treatment response were mostly part of primary trial papers, tended to be post hoc, and were biased toward positive findings.The alternative text for this image may have been generated using AI.

a Stacked bar graphs showing relative frequencies and percentages of papers with precision analyses that were defined as prespecified, post hoc, or included both prespecified and post hoc analyses in the manuscript text. b Stacked bar graph displaying relative frequencies and percentages of papers reporting positive findings related to associations with treatment effects. c For papers that listed sample sizes of subgroups tested for differential treatment effects (only 53% of all papers with precision analyses), the smallest sample size reported is displayed, with mean and SEM indicated. F/u follow-up; n = 9 for precision papers; n = 16 for primary trials; n = 5 for f/u papers.

Back to article page